Heron Therapeutics' (HRTX) Price Target Raised to $54 at BofA/Merrill Lynch

Go back to Heron Therapeutics' (HRTX) Price Target Raised to $54 at BofA/Merrill Lynch
HERON THERAPEUTICS (NASDAQ: HRTX) Delayed: 0.30 +0.03 (11.11%)
Previous Close $0.27    52 Week High $31.32 
Open $0.28    52 Week Low $13.95 
Day High $0.30    P/E N/A 
Day Low $0.27    EPS $-3.29 
Volume 1,152,136